tiprankstipranks
Trending News
More News >
Amphastar Pharmaceuticals (AMPH)
NASDAQ:AMPH
US Market

Amphastar Pharmaceuticals (AMPH) Income Statement

Compare
432 Followers

Amphastar Pharmaceuticals Income Statement

Last quarter (Q3 2025), Amphastar Pharmaceuticals's total revenue was $191.84M, an increase of 1.60% from the same quarter last year. In Q3, Amphastar Pharmaceuticals's net income was $17.35M. See Amphastar Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 731.97M$ 644.39M$ 498.99M$ 437.77M$ 349.85M
Gross Profit
$ 373.86M$ 351.12M$ 248.86M$ 199.74M$ 143.34M
Operating Expenses
$ 168.44M$ 154.13M$ 141.36M$ 129.85M$ 132.39M
Depreciation and Amortization
$ 57.20M$ 41.78M$ 28.27M$ 26.53M$ 25.18M
EBITDA
$ 277.31M$ 240.29M$ 146.16M$ 111.56M$ 30.19M
Operating Income
$ 205.42M$ 196.99M$ 107.50M$ 69.89M$ 10.95M
Other Income/Expenses
$ -16.23M$ -27.61M$ 7.37M$ 14.04M$ -6.32M
Pretax Income
$ 189.19M$ 169.38M$ 114.86M$ 83.93M$ 4.64M
Net Income
$ 159.52M$ 137.54M$ 91.39M$ 62.12M$ 1.40M
Per Share Metrics
Basic EPS
$ 3.29$ 2.85$ 1.88$ 1.30$ 0.03
Diluted EPS
$ 3.06$ 2.60$ 1.74$ 1.25$ 0.03
Weighted Average Shares Outstanding
48.43M 48.27M 48.55M 47.78M 47.04M
Weighted Average Shares Outstanding (Diluted)
52.06M 53.00M 52.43M 49.78M 49.12M
Currency in USD

Amphastar Pharmaceuticals Earnings and Revenue History